GRP75-driven, cell-cycle-dependent macropinocytosis of Tat/pDNA-Ca2+ nanoparticles underlies distinct gene therapy effect in ovarian cancer
Authors:
Open Access
- 20 July 2022
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 20 (1) , 1-20
Abstract
Practice of tumor-targeted suicide gene therapy is hampered by unsafe and low efficient delivery of plasmid DNA (pDNA). Using HIV-Tat-derived peptide (Tat) to non-covalently form Tat/pDNA complexes advances the delivery performance. However, this innovative approach is still limited by intracellular delivery efficiency and cell-cycle status. In this study, Tat/pDNA complexes were further condensed into smaller, nontoxic nanoparticles by Ca2+addition. Formulated Tat/pDNA-Ca2+nanoparticles mainly use macropinocytosis for intercellular delivery, and their macropinocytic uptake was persisted in mitosis (M-) phase and highly activated in DNA synthesis (S-) phase of cell-cycle. Over-expression or phosphorylation of a mitochondrial chaperone, 75-kDa glucose-regulated protein (GRP75), promoted monopolar spindle kinase 1 (MPS1)-controlled centrosome duplication and cell-cycle progress, but also driven cell-cycle-dependent macropinocytosis of Tat/pDNA-Ca2+nanoparticles. Further in vivo molecular imaging based on DF (Fluc-eGFP)-TF (RFP-Rluc-HSV-ttk) system showed that Tat/pDNA-Ca2+nanoparticles exhibited highly suicide gene therapy efficiency in mouse model xenografted with human ovarian cancer. Furthermore, arresting cell-cycle at S-phase markedly enhanced delivery performance of Tat/pDNA-Ca2+nanoparticles, whereas targeting GRP75 reduced their macropinocytic delivery. More importantly, in vivo targeting GRP75 combined with cell-cycle or macropinocytosis inhibitors exhibited distinct suicide gene therapy efficiency. In summary, our data highlight that mitochondrial chaperone GRP75 moonlights as a biphasic driver underlying cell-cycle-dependent macropinocytosis of Tat/pDNA-Ca2+nanoparticles in ovarian cancer.Keywords
Funding Information
- National Natural Science Foundation of China (81373318)
- National Translational Science Center for Molecular Medicine Fund (F1034361)
- Chinese Pharmacertical Association-Yiling Pharmacertical Innovation Fund (CPAYLJ202003)
- Key Research Fund of Tianjin Project & Team (XB202010)
- Key Research and Development Program of Tianjin (20YFZCSY00450)
- Tianjin sci-tech commissioner Fund (21YDTPJC00220)
This publication has 68 references indexed in Scilit:
- Protein adaptation: mitotic functions for membrane trafficking proteinsNature Reviews Molecular Cell Biology, 2013
- Endocytosis of Gene Delivery Vectors: From Clathrin-dependent to Lipid Raft-mediated EndocytosisMolecular Therapy, 2013
- Structural basis for Arf6–MKLP1 complex formation on the Flemming body responsible for cytokinesisThe EMBO Journal, 2012
- Dual channel rank-based intensity weighting for quantitative co-localization of microscopy imagesBMC Bioinformatics, 2011
- Redistribution of caveolae during mitosisJournal of Cell Science, 2011
- Single Particle Tracking Confirms That Multivalent Tat Protein Transduction Domain-induced Heparan Sulfate Proteoglycan Cross-linkage Activates Rac1 for InternalizationJournal of Biological Chemistry, 2011
- Magnetic nanoparticle-based isolation of endocytic vesicles reveals a role of the heat shock protein GRP75 in macromolecular deliveryProceedings of the National Academy of Sciences, 2010
- Endosomal recycling controls plasma membrane area during mitosisProceedings of the National Academy of Sciences, 2007
- Mortalin controls centrosome duplication via modulating centrosomal localization of p53Oncogene, 2006
- Role of calcium in gene deliveryExpert Opinion on Drug Delivery, 2006